$260 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 54 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 45.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Buy | Neurocrine Biosciences Inc | $16,061,000 | +25.8% | 163,500 | +6.2% | 6.17% | +23.8% |
| VRTX | Buy | Vertex Pharmaceuticals Inc | $14,144,000 | +27.2% | 83,222 | +22.0% | 5.43% | +25.2% |
| ILMN | New | Illumina Inc | $12,568,000 | – | 45,000 | +100.0% | 4.83% | – |
| ALXN | Buy | Alexion Pharmaceuticals Inc | $10,136,000 | +25.5% | 81,641 | +12.7% | 3.89% | +23.6% |
| EXEL | Buy | Exelixis Inc | $9,566,000 | +11.3% | 444,534 | +14.5% | 3.67% | +9.5% |
| BMRN | Buy | Biomarin Pharmaceutical Inc | $9,164,000 | +73.2% | 97,284 | +49.0% | 3.52% | +70.5% |
| INCY | Buy | Incyte Corp | $8,442,000 | +38.8% | 125,975 | +72.6% | 3.24% | +36.7% |
| HALO | Buy | Halozyme Therapeutics Inc | $7,227,000 | +2.9% | 428,633 | +19.5% | 2.78% | +1.2% |
| SPPI | New | Spectrum Pharmaceuticals Inc | $6,285,000 | – | 300,000 | +100.0% | 2.41% | – |
| ABMD | New | Abiomed Inc | $5,400,000 | – | 13,200 | +100.0% | 2.07% | – |
| XENT | Buy | Intersect Ent Inc | $4,189,000 | +188.5% | 112,000 | +202.7% | 1.61% | +184.3% |
| VSTM | Buy | Verastem Inc | $3,435,000 | +188.2% | 500,000 | +25.0% | 1.32% | +183.7% |
| MDGL | New | Madrigal Pharmaceuticals Inc | $2,790,000 | – | 10,000 | +100.0% | 1.07% | – |
| PBYI | Buy | Puma Biotechnology Inc | $2,732,000 | +18.2% | 46,300 | +36.2% | 1.05% | +16.3% |
| SGMO | Buy | Sangamo Therapeutics Inc | $1,605,000 | +59.9% | 113,000 | +113.2% | 0.62% | +57.1% |
| CRVS | New | Corvus Pharmaceuticals Inc | $892,000 | – | 81,341 | +100.0% | 0.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.